Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

EKF Diagnostics

EKF Diagnostics is a leading global diagnostics and biotechnology company that delivers advanced solutions in point-o... read more Featured Products: More products

Download Mobile App




Diagnostic Assay and Handheld Analyzers Exhibited in Dubai

By LabMedica International staff writers
Posted on 28 Jan 2015
A global diagnostics company exhibited its new early sepsis assay and point-of-care hemoglobin analyzer, and previewed its new lactate analyzer at Arab Health 2015.

EKF Diagnostics (Cardiff, UK) exhibited at Arab Health 2015 (January 26-29, Dubai, UAE) to highlight its new DiaSpect Tm handheld hemoglobin analyzer and new CE-marked Liquicolor Procalcitonin liquid-stable assay for early sepsis detection. More...
EKF also previewed SensPoint, a new handheld lactate analyzer with built-in connectivity functions to hospital or laboratory information systems.

DiaSpect Tm is a robust, heat and humidity compatible analyzer delivering immediate hemoglobin results at point-of-care (POC). The lightweight, palm-sized analyzer is reliable for anemia diagnosis in almost all climatic conditions. DiaSpect Tm combines laboratory-quality performance with unmatched measurement speed. Its extensive battery life of 40 days of continuous use, or 10,000 tests, enables long-term use outside of laboratories and in remote resource-poor locations.

DiaSpect Tm is proving highly effective in challenging POC testing (POCT) conditions in many locations, including east Africa and south-east Asia, where heat and humidity can affect performance of devices and blood collection cuvettes. DiaSpect Tm is unaffected by these environmental factors due to its reagent-free disposable cuvettes, and the fact that it has no moving parts.

The plexiglass micro-cuvettes used by DiaSpect Tm have a shelf life of 2.5 years when stored between 0–50 °C, so refrigeration is not necessary. Short-term storage is possible at -3–70 °C for a maximum of 24 hours. Also making it ideal for POCT is that DiaSpect Tm is factory calibrated against the HiCN reference method in accordance with ICSH and requires no recalibration or maintenance, as it undertakes an automatic self-check between every measurement.

DiaSpect Tm is easy to use and requires minimal training as the user simply collects a capillary or venous blood sample of <10 µL into the microcuvette and inserts it directly into the analyzer. Hemoglobin results are delivered in 1 second, and can be downloaded to a computer (via USB or Bluetooth).

The new CE-marked Liquicolor Procalcitonin liquid-stable immunoturbidimetric assay provides early and specific indication of sepsis and can be used on most automatic chemistry analyzers. Since Procalcitonin (PCT) levels elevate during systemic bacterial infection and sepsis, a PCT test can quickly assess initial sepsis severity. Liquicolor PCT is precise, convenient, and cost effective. It can remain stable on-board the analyzer for up to 4 weeks, and requires a minimal sample of just 20 µL. This assay can be run on a primary chemistry analyzer and eliminate the need for sample splitting, thus improving laboratory workflow.

Liquicolor Procalcitonin assay is currently unavailable for sale in USA, France, Germany, Austria, Spain, Italy, and Japan.

Related Links:

EKF Diagnostics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.